About the Product

Description


Nosniff SB Nasal Spray contains Xylometazoline and Sorbitol, a combination used for quick relief from nasal congestion, blocked nose, and sinus discomfort associated with cold, allergy, and rhinitis conditions.

Xylometazoline works as a nasal decongestant by narrowing swollen blood vessels in the nasal passages, while Sorbitol helps maintain moisture and reduces dryness for improved comfort.

This nasal spray is widely used in ENT care due to its fast action and effective symptom relief. It provides convenient administration and supports better breathing in congested conditions.

Some patients may experience nasal irritation, dryness, burning sensation, sneezing, or headache. Prolonged or excessive use may lead to rebound nasal congestion. Rarely, palpitations or increased blood pressure may occur.

Nosniff SB Nasal Spray (Xylometazoline 0.10% w/v + Sorbitol 2% w/v) is indicated for the temporary relief of nasal congestion associated with common cold, sinusitis, allergic rhinitis, and other upper respiratory allergies. It helps reduce nasal swelling and provides easier breathing.

Use this nasal spray only as directed by a healthcare professional. Do not use continuously for more than the recommended duration, as it may cause rebound congestion. Use with caution in patients with hypertension, heart disease, thyroid disorders, or diabetes. Avoid contact with eyes and do not share the spray bottle with others.

Store in a cool, dry place below 25°C, protected from direct sunlight. Keep the bottle tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Nosniff SB Nasal Spray in the PCD pharma franchise market?

Nosniff SB Nasal Spray, containing Xylometazoline 0.10% w/v and Sorbitol 2% w/v, has strong demand in the ENT and respiratory care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on nasal congestion and allergy relief portfolios.

Why should medical distributors include Nosniff SB Nasal Spray in their product range?

Medical distributors and agencies can benefit from the consistent demand for nasal decongestant sprays used in blocked nose, sinus congestion, allergic rhinitis, common cold, and respiratory discomfort. The addition of Sorbitol helps provide moisture and comfort, strengthening an ENT-focused product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Nosniff SB Nasal Spray?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Nosniff SB Nasal Spray with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Nosniff SB Nasal Spray distribution?

Wholesalers and medical agencies benefit from strong seasonal demand, fast-moving OTC sales, reliable supply chain support, and good margins when partnering for Nosniff SB Nasal Spray distribution.

How can I become a distributor or franchise partner for Nosniff SB Nasal Spray?

Medical distributors, stockists, and wholesalers interested in Nosniff SB Nasal Spray can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.